Back to search

Article

Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson’s disease

2024-04-04

Abstract excerpt

We address an unmet challenge in Parkinson’s disease: the lack of biomarkers to identify the right patients for the right therapy, which is a main reason clinical trials for disease modifying treatments have all failed. The gut microbiome is a new target for treatment of Parkinson’s disease, with potential to halt disease progression. Our aim was to develop microbiome-based biomarkers to guide patient selection fo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1dde3183-02ee-5a25-994c-78e5610f666a
DOI
10.1101/2024.04.03.24305273
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson’s diseaseDOI 10.1101/2024.04.03.24305273
Select a neighboring publication to make it the new centre.